AbbVie’s Humira gets a U.S. rival, but costs could stay high — benefiting PBMs, but not patients [more competition is coming]
Debt woes mount for US healthcare sector as interest rates rise — [some companies such as skilled nursing facilities and rural hospitals are making just enough money to continue operating]